FDA to Consider Easing Restrictions on Unproven Peptides Favored by RFK Jr.
The U.S. Food and Drug Administration (FDA) announced it will hold a meeting this July to consider easing restrictions on several unproven peptide injections. This move aligns with pledges by Health Secretary Robert F. Kennedy Jr., a prominent advocate for these therapies within his Make America Healthy Again movement. The FDA panel will review seven specific peptides, including BPC-157 and TB-500, to determine if they should be removed from a restrictive list that currently prohibits compounding pharmacies from producing them. Under the previous administration, these substances were barred due to significant safety risks and a lack of extensive human testing. However, Kennedy and various wellness influencers argue that these peptides offer benefits for injury healing, muscle building, and longevity. Kennedy has personally endorsed their use, claiming the prior ban was illegal. The upcoming review marks a potential regulatory shift, allowing wider access to these controversial, unapproved treatments despite limited scientific evidence supporting their safety and efficacy claims.
Wire timeline
FDA to Consider Easing Restrictions on Unproven Peptides Favored by RFK Jr.
The U.S. Food and Drug Administration (FDA) announced it will hold a meeting this July to consider easing restrictions on several unproven peptide injections. This move aligns with pledges by Health Secretary Robert F. Kennedy Jr., a prominent advocate for these therapies within his Make America Healthy Again movement. The FDA panel will review seven specific peptides, including BPC-157 and TB-500, to determine if they should be removed from a restrictive list that currently prohibits compounding pharmacies from producing them. Under the previous administration, these substances were barred due to significant safety risks and a lack of extensive human testing. However, Kennedy and various wellness influencers argue that these peptides offer benefits for injury healing, muscle building, and longevity. Kennedy has personally endorsed their use, claiming the prior ban was illegal. The upcoming review marks a potential regulatory shift, allowing wider access to these controversial, unapproved treatments despite limited scientific evidence supporting their safety and efficacy claims.
abcnews